REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 156 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322,632 | -18.8% | 19,601 | -1.4% | 0.00% | -20.0% |
| Q2 2023 | $397,221 | -1.9% | 19,871 | -7.2% | 0.01% | 0.0% |
| Q1 2023 | $404,787 | -65.2% | 21,406 | -58.2% | 0.01% | -37.5% |
| Q4 2022 | $1,161,806 | +51.5% | 51,226 | +76.5% | 0.01% | -27.3% |
| Q3 2022 | $767,000 | +4.8% | 29,028 | -2.0% | 0.01% | +10.0% |
| Q2 2022 | $732,000 | -32.5% | 29,626 | -9.3% | 0.01% | -16.7% |
| Q1 2022 | $1,084,000 | +6.4% | 32,661 | +4.8% | 0.01% | +9.1% |
| Q4 2021 | $1,019,000 | – | 31,173 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |